To add.. believe PRED is a 20B company, with revenue potentials in the next year of 5B and over 1B in net income. The Endo Market alone is worth 1B+ in revenues, but considering all of the applications for their genetic database (both internally and through partnership), this grows up to the target quickly.
The $100 PPS estimates IMO are VERY realistic within the next year or two. If PRED hits the revenue/income numbers above that alone justifies at industry average PPS multipliers.
That all being said, I am holding to $15 by year end as my target price. I think the higher ranges are possible, but hinge greatly off of additional news and company intent.
Market Data 
Markets 
